Product finder

recomBead EBV

Luminex®-based immunoassay (MagPlex®) for the detection of IgG or IgM antibodies
against Epstein-Barr virus in human serum or plasma
  1. /
  2. Products & Automation
  3. /
  4. Product finder

Mikrogen recomBead EBV tests are quantitative immunoassays, using recombinantly produced antigens, for the detection of human antibodies against diagnostically relevant EBV antigens. They allow differentiation between initial infection and past infection or exclusion of Epstein-Barr virus infection.

Products

recomBead EBV IgG 2.0
Reagents for 96 determinations
 Article no.: 4554 Request

recomBead EBV IgM 2.0
Reagents for 96 determinations
 Article no.: 4555 Request

Advantages

  • Reliable screening by recombinant antigens:
EBV antigen groups Abbreviation Recombinant antigen IgG IgM
Immediate early antigen IEA BZLF1 yes yes
Early antigen EA p54, p138 yes yes

Virus capsid/structural antigen

 VCA p23 yes no
p18 yes yes
Nuclear antigen EBNA-1 p72 yes no
  • Reliable detection of past infections due to very high EBNA-1 specificity
  • Reliable detection of acute infections due to very high sensitivity of early antigens
  • Informative EBV diagnostics: simultaneous, separate detection of all relevant EBV antigens allows classification into early and late phase EBV infection
  • Ideally suited for high sample throughput
  • Fully automated processing, software-based evaluation (recomQuant) and connection to the laboratory information system possible

Safe and reliable

Validity check by integrated controls (incubation, conjugate and negative control)

Flexible and compatible

Combination of all Mikrogen recomBead immunoassays possible on one plate - uniform processing and interchangeable reagents

High Standard

CE marking: Our recomBead EBV tests meet the high requirements of the EC Directive 98/79/EC for in vitro diagnostic medical devices